A view of the Merck & Co. campus in Linden, N.J., on March 9, 2009. Jeff Zelevansky/ReutersBiotech giant Merck announced plans on Nov. 14 to acquire Cidara Therapeutics for $9.2 billion to develop medications for the prevention of influenza.In a company statement, Merck Chairman and CEO Robert Davis said the deal will enable the company to augment its pharmaceuticals with CD388, a long-acting antiviral designed to prevent influenza in individuals at high risk of complications.
Ohio State Agrees to $2.1 Million Federal Settlement Over Undisclosed China Research Ties
Ohio State University has agreed to pay $2.1 million to resolve federal...
USDA Unveils New Support for Ranchers to Rebuild Cattle Herds
The U.S. Department of Agriculture has unveiled a new package of measures...
How Major US Stock Indexes Fared Aug. 31
Oil prices rose and U.S. stocks fell after American forces struck Iranian...
Trump Unveils New Drug Pricing Deals With 9 Pharmaceutical Companies
President Donald Trump on Aug. 31 announced agreements with nine midsize pharmaceutical...
